Literature DB >> 12556570

Are late-onset schizophrenia spectrum disorders neurodegenerative conditions? Annual rates of change on two dementia measures.

Barton W Palmer1, Mark W Bondi, Elizabeth W Twamley, Leon Thal, Shahrokh Golshan, Dilip V Jeste.   

Abstract

Some investigators assert that emergence of schizophrenia spectrum disorders in mid- to late life (LOSD, i.e., onset after age 45) reflects neurodegenerative processes. The authors examined 1- and 2-year changes among 37 outpatients with LOSDs on the Mini-Mental State Examination (MMSE) and Mattis Dementia Rating Scale, compared with 69 patients having earlier-onset schizophrenia spectrum disorders (EOSD), 67 having Alzheimer's disease (AD) with psychosis, 72 having AD with baseline MMSE scores >/=24, and 56 normal comparison subjects (NCs). Cognitive changes among LOSD patients were similar to those in EOSD patients and NCs, whereas the AD groups had greater declines. Results support viewing LOSDs as static encephalopathies.

Entities:  

Mesh:

Year:  2003        PMID: 12556570     DOI: 10.1176/jnp.15.1.45

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  12 in total

Review 1.  Late-onset schizophrenia: do recent studies support categorizing LOS as a subtype of schizophrenia?

Authors:  Jeanne E Maglione; Scot E Thomas; Dilip V Jeste
Journal:  Curr Opin Psychiatry       Date:  2014-05       Impact factor: 4.741

2.  Prevalence and correlates of adequate performance on a measure of abilities related to decisional capacity: differences among three standards for the MacCAT-CR in patients with schizophrenia.

Authors:  Laura B Dunn; Barton W Palmer; Paul S Appelbaum; Elyn R Saks; Gregory A Aarons; Dilip V Jeste
Journal:  Schizophr Res       Date:  2006-10-03       Impact factor: 4.939

Review 3.  Is there evidence for late cognitive decline in chronic schizophrenia?

Authors:  Jharna N Shah; Salah U Qureshi; Ali Jawaid; Paul E Schulz
Journal:  Psychiatr Q       Date:  2012-06

Review 4.  New wine in old bottle: late-life psychosis.

Authors:  Alana Iglewicz; Thomas W Meeks; Dilip V Jeste
Journal:  Psychiatr Clin North Am       Date:  2011-06

5.  Differentiating the cognitive profile of schizophrenia from that of Alzheimer disease and depression in late life.

Authors:  Christina Ting; Tarek K Rajji; Zahinoor Ismail; David F Tang-Wai; Nina Apanasiewicz; Dielle Miranda; David Mamo; Benoit H Mulsant
Journal:  PLoS One       Date:  2010-04-12       Impact factor: 3.240

6.  Characterizing trajectories of cognitive functioning in older adults with schizophrenia: does method matter?

Authors:  Wesley K Thompson; Gauri N Savla; Ipsit V Vahia; Colin A Depp; Ruth O'Hara; Dilip V Jeste; Barton W Palmer
Journal:  Schizophr Res       Date:  2012-12-05       Impact factor: 4.939

7.  Cognitive performance of individuals with schizophrenia across seven decades: a study using the MATRICS consensus cognitive battery.

Authors:  Tarek K Rajji; Aristotle N Voineskos; Meryl A Butters; Dielle Miranda; Tamara Arenovich; Mahesh Menon; Zahinoor Ismail; Robert S Kern; Benoit H Mulsant
Journal:  Am J Geriatr Psychiatry       Date:  2013-01-22       Impact factor: 4.105

8.  Short-term course of neuropsychological abilities in middle-aged and older adults with bipolar disorder.

Authors:  Colin A Depp; Gauri N Savla; David J Moore; Barton W Palmer; John L Stricker; Barry D Lebowitz; Dilip V Jeste
Journal:  Bipolar Disord       Date:  2008-09       Impact factor: 6.744

9.  Physical and mental health-related quality of life among older people with schizophrenia.

Authors:  David P Folsom; Colin Depp; Barton W Palmer; Brent T Mausbach; Shahrokh Golshan; Ian Fellows; Veronica Cardenas; Thomas L Patterson; Helena C Kraemer; Dilip V Jeste
Journal:  Schizophr Res       Date:  2009-01-24       Impact factor: 4.939

Review 10.  Schizophrenia in late life: emerging issues.

Authors:  David P Folsom; Barry D Lebowitz; Laurie A Lindamer; Barton W Palmer; Thomas L Patterson; Dilip V Jeste
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.